• DAAs cost-effective for reducing HCV in people who inject drugs

    3 monthes ago - By Healio

    Scaling up access to direct-acting antivirals, or DAAs, is the most cost-effective intervention for reducing hepatitis C virus among people who inject drugs when only health sector costs are considered, according to findings from a computer simulation study.
    However, when criminal justice system-related costs are included, DAA coverage combined with medication-assisted treatment with syringe access programs, or MAT+, is the most cost-effective strategy, researchers reported.
    “Without an aggressive approach that combats both the HCV itself and the injection drug use behaviors associated
    Read more ...